Creating a database for rectal cancer patients
Development of a Monocentric and Prospective Clinical and Biological Database in Rectum Cancer
NA · Institut du Cancer de Montpellier - Val d'Aurelle · NCT04006951
This study is creating a database of blood and tissue samples from rectal cancer patients to help researchers find better treatments and understand how to manage the disease.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut du Cancer de Montpellier - Val d'Aurelle (other) |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Montpellier) |
| Trial ID | NCT04006951 on ClinicalTrials.gov |
What this trial studies
This initiative aims to develop a clinical and biological database specifically for rectal cancer, collecting blood and tissue samples along with clinical data. The goal is to enhance understanding of rectal neoplasms and facilitate the development of new treatment options. By sharing these resources with the scientific community, the project seeks to identify predictive markers for treatment response and improve patient management. The Montpellier Cancer Institute is leading this effort to address the challenges faced in treating locally advanced rectal carcinoma.
Who should consider this trial
Good fit: Ideal candidates include patients over 18 years old receiving treatment at the Montpellier Cancer Institute for rectal cancer.
Not a fit: Patients who are not affiliated with the Social Protection system or those unable to comply with study requirements may not benefit from this study.
Why it matters
Potential benefit: If successful, this project could lead to improved treatment strategies and outcomes for patients with rectal cancer.
How similar studies have performed: Other studies have shown success in utilizing biological collections to advance cancer research, making this approach promising.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient treated at the Montpellier Cancer Institute, whatever the treatment received (systemic cancer treatment or radiotherapy or surgery) * Age \> 18 years * Signed informed consent Exclusion Criteria: * Patient not affiliated to Social Protection system * Patient unable to understand or comply with study instructions or requirements for psychological, family, social or geographical reasons * Patient under guardianship
Where this trial is running
Montpellier
- ICM Val d'Aurelle — Montpellier, France (RECRUITING)
Study contacts
- Study coordinator: Aurore MOUSSION
- Email: drci-icm105@icm.unicancer.fr
- Phone: 4 67 61 31 02
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Rectal Neoplasms, Cancer, Colorectal cancer, Biological Specimen Banks